INCELL is also partnered in developing new mechanism anti-microbial antibiotics technology that uses alternate mechanisms to kill bacteria or inhibit their growth. This will include multi-drug resistant bacteria, such as Methicillin Resistant Staphylococcus Aureus (MRSA) or Tuberculosis Bacillus (TB). It also includes microbes that can form resistant biofilms, e.g., Pseudomonas, as part of their disease-causing process and/or are biothreats such as Yersinia pestis, which causes bubonic plague. |
|
